SPDR MSCI Europe Health Care UCITS ETF EUR

Reference Data

ISIN IE00BKWQ0H23
Valor Number 24767202
Bloomberg Global ID
Fund Name SPDR MSCI Europe Health Care UCITS ETF EUR
Fund Provider State Street Investment Management Kalanderplatz 5, 8045 Zürich
E-Mail: spdrsswitzerland@statestreet.com
Web: www.statestreet.com/im
spdrsswitzerland@statestreet.com (ETF Business)
Fund Provider State Street Investment Management
Representative in Switzerland State Street Bank GmbH, München, Zweigniederlassung Zürich
Zürich
Phone: +41 44 560 50 00
Distributor(s) State Street Global Advisors
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Ireland
Issuing Condition Combination of issuing commission charged by the fund management company and transaction fee charged by the fund
Redemption Condition Combination of redemption commission charged by the fund management company and transaction fee charged by the fund
Investment Strategy *** The investment objective of the Fund is to track the performance of European large and midsized companies in the Health Care sector.
Peculiarities

Fund Prices

Current Price * 208.90 EUR 04.09.2025
Previous Price * 208.77 EUR 03.09.2025
52 Week High * 240.74 EUR 09.09.2024
52 Week Low * 182.04 EUR 09.04.2025
NAV * 208.90 EUR 04.09.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 679,334,714
Unit/Share Assets *** 679,334,714
Trading Information SIX

Performance

YTD Performance -0.38% 31.12.2024
04.09.2025
YTD Performance (in CHF) -0.64% 31.12.2024
04.09.2025
1 month +6.65% 04.08.2025
04.09.2025
3 months +0.50% 04.06.2025
04.09.2025
6 months -9.61% 04.03.2025
04.09.2025
1 year -14.19% 04.09.2024
04.09.2025
2 years +1.82% 04.09.2023
04.09.2025
3 years +14.37% 05.09.2022
04.09.2025
5 years +35.81% 04.09.2020
04.09.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

AstraZeneca PLC 14.41%
Novartis AG Registered Shares 14.04%
Roche Holding AG 13.35%
Novo Nordisk AS Class B 10.57%
Sanofi SA 6.38%
Essilorluxottica 5.35%
GSK PLC 4.68%
Lonza Group Ltd 2.91%
Haleon PLC 2.58%
argenx SE 2.52%
Last data update 31.08.2025

Cost / Risk

TER *** 0.18%
TER date *** 31.03.2025
Performance Fee ***
PTR
Max. Management Fee *** 0.18%
Ongoing Charges *** 0.18%
SRRI ***
SRRI date *** 31.08.2025

Breakdowns

Equity Countries ***

Equity Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)